Bristol-Myers Squibb Co

BMY

Company Profile

  • Business description

    Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

  • Contact

    Route 206 and Province Line Road
    Princeton
    New JerseyNJ08543
    USA

    T: +1 609 252-4621

    E: [email protected]

    https://www.bms.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    34,100

Stocks News & Analysis

stocks

10 best US blue-chip stocks to buy for the long term

The stocks of these high-quality companies with large market capitalisations look undervalued today.
personal-finance

US stock market outlook: tariffs are 2025's wild card

Macrodynamic tailwinds persist, but stocks are already priced to perfection. Will tariffs derail the market in 2025?
stocks

5 undervalued US stocks that crushed earnings

Names like Sony and GSK are still cheap despite impressive earnings beats for Q2 2024.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,052.7080.40-0.99%
CAC 407,598.98259.85-3.31%
DAX 4021,717.39673.45-3.01%
Dow JONES (US)40,545.931,679.39-3.98%
FTSE 1008,474.74133.74-1.55%
HKSE22,849.81352.72-1.52%
NASDAQ16,550.611,050.44-5.97%
Nikkei 22534,735.93989.94-2.77%
NZX 50 Index12,187.17151.40-1.23%
S&P 5005,396.52274.45-4.84%
S&P/ASX 2007,859.7074.80-0.94%
SSE Composite Index3,342.018.12-0.24%

Market Movers